1. Home
  2. IgG4-Related Disease Doctors Near Me
  3. Clinical Trials
  4. Rheumatologic Biobank for Clinical and Basic Research: Isolation, Extraction and Storage of Protein, DNA and RNA Extracted From Tissues of Patients With Rheumatoid Diseases

IgG4-Related Disease Clinical Trials

Find IgG4-Related Disease Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Rheumatologic Biobank for Clinical and Basic Research: Isolation, Extraction and Storage of Protein, DNA and RNA Extracted From Tissues of Patients With Rheumatoid Diseases

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research, following approval of each specific study by the IRB. The investigators intend to extract protein, DNA and RNA from each sample.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:

• above 18 years of age

• willing to sign informed consent

• have a rheumatoid condition

Locations
Other Locations
Israel
Meir Medical Center
RECRUITING
Kfar Saba
Contact Information
Primary
Yair Levy, Prof.
levy.yair@clalit.org.il
972-9-7471524
Backup
Noa Rabinowicz, Dr.
noa.rabinowicz@clalit.org.il
972-9-7471992
Time Frame
Start Date: 2018-04-16
Estimated Completion Date: 2037-11
Participants
Target number of participants: 500
Treatments
RA patients
before or after medication
Systemic sclerosis patients
before or after medication
IgG4 RD patients
before or after medication
Lupus patients
before or after medication
Authors
Yar Levy
Related Therapeutic Areas
IgG4-Related Disease
Rheumatoid Arthritis (RA)
Dry Mouth
Arthritis
Sjogren Syndrome
Dry Eye Syndrome
Systemic Lupus Erythematosus (SLE)
Scleroderma
Systemic Sclerosis (SSc)
Sponsors
Leads: Meir Medical Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

Evaluation of the Safety and Efficacy of the BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases: A Single-center Exploratory Clinical Study

Evaluation of the Safety and Efficacy of the BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases: A Single-center Exploratory Clinical Study

Enrollment Status: Recruiting
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 1

A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease

A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease

Enrollment Status: Recruiting
Publish Date: April 08, 2026
Intervention Type: Drug
Study Phase: Phase 3

A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease

A Phase IIa, Single-Site, Open-Label Study of Efgartigimod in Patients With IgG4-Related Disease

Enrollment Status: Recruiting
Publish Date: February 10, 2026
Intervention Type: Drug
Study Phase: Phase 2
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved